# Investors

Type: Person

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/investors-person
Canonical HTML page: https://getlegalbrief.com/entity/investors-person

## Timeline

- **2026-Q3**: Lead Counsel Appointment — Expected timeframe for the court to designate the lead plaintiff and legal representation.
- **2026-05-11**: Lead Plaintiff Deadline — Final day for affected investors to petition the court to lead the class action.
- **2026-03-12**: Lawsuit Announcements — Schall Law Firm files class action notices for Soleno Therapeutics and Ultragenyx Pharmaceutical.

## Recent coverage (1 stories)

### Schall Law Firm Targets Soleno and Ultragenyx in Dual Securities Fraud Actions
2026-03-12 10:04:00 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

The Schall Law Firm has initiated securities fraud class actions against Soleno Therapeutics and Ultragenyx Pharmaceutical, alleging violations of federal securities laws. The firm is currently seeking lead plaintiffs to represent the class in these high-stakes biotech litigations following potential misrepresentations to the market.
Full story: https://getlegalbrief.com/story/schall-law-firm-soleno-ultragenyx-securities-fraud

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.